Akari Therapeutics (AKTX) Receivables - Net (2011 - 2013)
Akari Therapeutics (AKTX) posted quarterly Receivables - Net of $6000.0 for Q4 2013, down 50.0% year-on-year from $12000.0 in Q4 2012, and down 50.0% on a QoQ basis from $12000.0 in Q4 2012.
Akari Therapeutics (AKTX) Receivables - Net (2011 - 2013) Analysis & Trends
Akari Therapeutics (AKTX) has reported Receivables - Net for 3 consecutive years, with $6000.0 the latest figure, recorded in Q4 2013.
- Quarterly Receivables - Net fell 50.0% year-over-year to $6000.0 in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $6000.0 (down 50.0% YoY) and the FY2013 annual result came in at $6000.0, down 50.0% from the prior year.
- Receivables - Net retreated to $6000.0 in Q4 2013 per AKTX's latest filing, from $12000.0 in the prior quarter.
- Over the last five years, Receivables - Net for AKTX reached as high as $19000.0 in Q4 2011 and fell as low as $6000.0 in Q4 2013.
- A 3-year average of $12333.3 and a median of $12000.0 in 2012 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2012 — Receivables - Net sank 36.84% — and 2013, when it plunged 50.0%.
- Year by year, Receivables - Net stood at $19000.0 in 2011, then slumped by 36.84% to $12000.0 in 2012, then tumbled by 50.0% to $6000.0 in 2013.
- According to Business Quant data, Receivables - Net over the past three periods registered $6000.0, $12000.0, and $19000.0 for Q4 2013, Q4 2012, and Q4 2011 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Akari Therapeutics | 86.55 Mn | 86.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 6,000.00 |
| Dec 31, 2013 | 6,000.00 |
| Dec 31, 2012 | 12,000.00 |
| Dec 31, 2012 | 12,000.00 |
| Dec 31, 2011 | 19,000.00 |
| Dec 31, 2011 | 19,000.00 |